Apolipoprotein E and Alzheimer's disease: The protective effects of ApoE2 and E3

Journal of Alzheimer's Disease

Volumn 4, Issue 3, 2002, Pages 145-154

  Rebeck, G William ^a   Kindy, Mark ^a   LaDu, Mary Jo ^a  

^a ENH Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3;

ALZHEIMER DISEASE; CELL REGENERATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HUMAN; NERVE FIBER GROWTH; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN METABOLISM; REVIEW;

EID: 0036592640     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2002-4304     Document Type: Review

References (158)

1. Interaction of nascent apoE2, apoE3, and apoE4 isoforms expressed in mammalian cells with amyloid peptide β(1-40): Relevance to Alzheimer's disease
2. Progression of cerebral amyloid angiopathy: Accumulation of amyloid-beta40 in affected vessels
3. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition
4. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E
5. Isoform-specific modulation by apolipoprotein E of the activities of secreted β-amyloid precursor protein
6. Apolipoprotein E isoform-specific reduction of extracellular amyloid in neuronal cultures
7. Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth
8. Apolipoprotein E genes in Lewy body and Parkinson's disease
9. Apolipoprotein E immunoreactivity within neurofibrillary tangles: Relationship to tau and PHF in Alzheimer's disease
10. Rapid induction of intraneuronal neurofibrillary tangles in apolipoprotein E-deficient mice
11. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system
12. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve
13. Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke
14. Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons
15. Reversal of presynaptic deficits of apolipoprotein E-deficient mice in human apolipoprotein E transgenic mice
16. Apolipoprotein E, e4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: Analysis of the 19q13.2 chromosomal region
17. SP-40,40 is a constituent of Alzheimer's amyloid
18. Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease
19. Expression and alternative splicing of apolipoprotein E receptor 2 in brain
20. Influence of lipoproteins on microglial degradation of Alzheimer's amyloid beta-protein
21. Lipoprotein effects on Abeta accumulation and degradation by microglia in vitro
22. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
23. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
24. A test of the cytosolic apolipoprotein E hypothesis fails to detect the escape of apolipoprotein E from the endocytic pathway into the cytosol and shows that direct expression of apolipoprotein E in the cytosol is cytotoxic
25. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes
26. ApoE protects cortical neurones against neurotoxicity induced by the non-fibrillar C-terminal domain of the amyloidbeta peptide
27. Microglial activation in Alzheimer disease: Association with APOE genotype
28. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: Implications for the pathogenesis and treatment of Alzheimer's disease
29. Differential binding of apolipoprotein E isoforms to tau and other cytoskeletal proteins
30. Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease
31. Apolipoprotein E is found in astrocytes but not in microglia in the normal mouse brain
32. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
33. Neuropathology and apolipoprotein E profile of aged chimpanzees: Implications for Alzheimer disease
34. The cerebrospinalfluid form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex
35. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease
36. Cholesterol from degenerating nerve myelin becomes associated with lipoproteins containing apolipoprotein E
37. Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy
38. Glial-neuronal interactions in Alzheimer's disease: The potential role of a'cytokine cycle' in disease progression
39. Apolipoprotein E and low-density lipoprotein binding and internalization in primary cultures of rat astrocytes: Isoformspecific alterations
40. Protofibrils, the unifying toxic molecule of neurodegenerative disorders?
41. Co-localization of beta-amyloid peptides, apolipoprotein E and glial markers in senile plaques in the prefrontal cortex of old rhesus monkeys
42. Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons
43. The LDL receptor gene family: (un)expected signal transducers in the brain
44. Apolipoprotein E isoformdependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease
45. In vivo expression of apolipoprotein E reduces amyloid-β deposition in a mouse model of Alzheimer's disease
46. LRP mediates apolipoprotein E-dependent neurite outgrowth in a CNS-derived neuronal cell line
47. Confirmation that the ApoE4 allele is associated with late onset, familial Alzheimer's disease
48. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice
49. Apolipoprotein E attenuates beta-amyloid-induced astrocyte activation
50. Isoform-specific interactions of apolipoprotein E with the microtubule-associated protein MAP2c: Implications for Alzheimer's disease
51. ApoE3 binding to tau tandem repeat I is abolished by tau serine262 phosphorylation
52. Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons
53. Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype
54. Apolipoprotein E in nerve injury and repair
55. Expression of apolipoprotein E during nerve degeneration and regeneration
56. Lipoprotein uptake by neuronal growth cones in vitro
57. Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid beta-peptide deposition in homozygous APP(V717F) transgenic mice
58. Isoform-specific effect of apolipoprotein E on cell survival and β-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures
59. Amyloid beta-peptide effects on synaptosomes from apolipoprotein E-deficient mice
60. Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain
61. Targeting small Abeta oligomers: The solution to an Alzheimer's disease conundrum?
62. Cholinergic systems and long-term potentiation in memory-impaired apolipoprotein E-deficient mice
63. Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains
64. Isoform-specific binding of apolipoprotein E to β-amyloid
65. Nascent astrocyte particles differ from lipoproteins in CSF
66. Association of human, rat, and rabbit apolipoprotein E with beta-amyloid
67. Purification of apolipoprotein E attenuates isoform-specific binding to β-amyloid
68. Apolipoprotein E and apolipoprotein E receptors modulate A beta-induced glial neuroinflammatory responses
69. Apolipoprotein E receptors mediate the effects of beta-amyloid on astrocyte cultures
70. APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome
71. Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins
72. Evolution of amyloid: What normal protein folding may tell us about fibrillogenesis and disease
73. Apolipoprotein E suppresses glial cell secretion of TNF alpha
74. Endogenous apolipoprotein E suppresses LPS-stimulated microglial nitric oxide production
75. Apolipoprotein E-deficient mice have increased susceptibility to focal cerebral ischemia
76. Increased levels of alpha-1-antichymotrypsin in brains of patients with Alzheimer's disease correlate with activated astrocytes and are affected by APOE 4 genotype
77. Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response
78. Alzheimer A beta neurotoxicity: Promotion by antichymotrypsin, ApoE4; inhibition by A beta-related peptides
79. Amyloid-associated proteins alpha-1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer betaprotein into filaments
80. Apolipoprotein E genotype and Alzheimer's disease in Hong Kong elderly Chinese
81. A thrombin cleavage fragment of apolipoprotein E exhibits isoform-specific neurotoxicity
82. Expression of alpha(2)-macroglobulin receptor/low density lipoprotein receptor-related protein (LRP) in rat microglial cells
83. Abnormal synaptic regeneration in hAPP695 transgenic and apoE knockout mice
84. Neurodegeneration in the central nervous system of apoE-deficient mice
85. Characterization of apolipoprotein J-Alzheimer's Aβ interaction
86. CNS synaptogenesis promoted by glia-derived cholesterol
87. Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: Implications for Alzheimer's disease
88. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides
89. Apolipoprotein E expression in astrocytes: Developmental pattern and regulation
90. Apolipoprotein E-immunoreactivity in aged rhesus monkey cortex: Colocalization with amyloid plaques
91. Apolipoprotein E epsilon 4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis
92. Expression of apoE mRNA in rat microglia
93. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease kuru plaque amyloid in Creutzfeldt-Jacob disease
94. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro
95. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization
96. Amyloid beta-protein, APOE genotype and head injury
97. ApoE E4 allele is associated with deposition of amyloid beta-protein following head injury
98. Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress
99. The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant
100. Astrogliosis and the ApoE genotype. An immunohistochemical study of postmortem human brain tissue
101. A mechanism for the neuroprotective effect of apolipoprotein E: Isoform-specific modification by the lipid peroxidation product 4-hydroxynonenal
102. Alzheimer's disease and apolipoprotein E-4 allele in an Amish population
103. Neuronal injury-induced expression and release of apolipoprotein E in mixed neuron/glia co-cultures: Nuclear factor kappaB inhibitors reduce basal and lesion-induced secretion of apolipoprotein E
104. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins
105. Lipoproteins and their receptors in the central nervous system
106. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease
107. Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats
108. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning
109. Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein
110. Effect of apolipoprotein E on neurite outgrowth and beta-amyloid-induced toxicity in developing rat primary hippocampal cultures
111. Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein
112. Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals
113. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions
114. Oligomerization and fibril assembly of the amyloid-beta protein
115. Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease
116. Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down's syndrome from dementia
117. Susceptibility of transgenic mice expressing human apolipoprotein E to closed head injury: The allele E3 is neuroprotective whereas E4 increases fatalities
118. Glial cells in Alzheimer's disease: Preferential effect of APOE risk on scattered microglia
119. Apolipoprotein E associates with β amyloid peptide of Alzheimer's disease to form novel monofibrils
120. Apolipoprotein E ε4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases
121. Differential regulation of astrocytic mRNAs in the rat striatum after lesions of the cortex or substantia nigra
122. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein genotype in late-onset Alzheimer disease
123. Alzheimer's disease: Genes, proteins, and therapy
124. Apolipoprotein E epsilon-4 and the risk of dementia with stroke-a population based investigation
125. The Sixth International Conference on Alzheimer's disease, Amsterdam, The Netherlands, July 1998. The amyloid cascade hypothesis debate: Emerging consensus on the role of A beta and amyloid in Alzheimer's disease
126. The relationship between apolipoprotein E and serum oxidation-related variables is apolipoprotein E phenotype dependent
127. Macrophages in the peripheral nervous system and astroglia in the central nervous system of rat commonly express apolipoprotein E during development but differ in their response to injury
128. Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro
129. Apolipoprotein E and Alzheimer disease
130. Isoform-specific interactions of apolipoprotein E with microtubule-associated tau: Implications for Alzheimer disease
131. Apolipoprotein E: High avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
132. Hypothesis: Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype
133. Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis
134. GFAP-apoE transgenic mice: Astrocyte specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins
135. Apolipoprotein E deposition and astrogliosis are associated with maturation of beta-amyloid plaques in betaAPPswe transgenic mouse: Implications for the pathogenesis of Alzheimer's disease
136. Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice
137. Role of apolipoprotein E and estrogen in mossy fiber sprouting in hippocampal slice cultures
138. Human apolipoprotein E isoform-specific differences in neuronal sprouting in organotypic hippocampal culture
139. Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid β-peptide
140. Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity
141. Neurotoxicity of the 22kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated
142. Apolipoprotein E: Risk factor for Alzheimer disease
143. ApoE immunoreactivity and microglial cells in Alzheimer's disease brain
144. Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: Implications for cerebral amyloid angiopathy
145. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease
146. Synaptic alterations in apolipoprotein E knockout mice
147. Role of apolipoprotein E receptors in regulating the differential in vivo neurotrophic effects of apolipoprotein E
148. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates
149. Attenuation of the neurotoxic effect of A beta amyloid peptide by apolipoprotein E
150. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro
151. Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid
152. Apolipoprotein E: Binding to soluble Alzheimer's beta-amyloid
153. Alzheimer beta amyloid deposition enhanced by apoE epsilon4 gene precedes neurofibrillary pathology in the frontal association cortex of nondemented senior subjects
154. Characterization of the binding of amyloid-β peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma
155. Apolipoprotein E promotes the binding and uptake of beta-amyloid into Chinese hamster ovary cells in an isoform-specific manner
156. The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer disease
157. Modulation of the age at onset of Parkinson's disease by apolipoprotein E genotype
158. Alzheimer amyloid-beta peptide forms denaturant-resistant complex with type epsilon 3 but not type epsilon 4 isoform of native apolipoprotein E